Hemodynamic optimization, intestinal damage, ERAS, gastrointestinal disease. Hemodynamische optimalisatie, intestinale schade, ERAS, gastrointestinale aandoeningen.
Conditions
Interventions
Fluid and/or noradrenaline administration based on cardiac output in/decrease and mean arterial pressure.
The control group will receive standard care. The intervention group will receive standard c
Sponsors
Maastricht University Medical Center +
Eligibility
Inclusion criteria
Inclusion criteria: 1. All patients undergoing elective colorectal surgery with anastomosis; 2. Minimum age 18 years; 3. Giving informed consent.
Exclusion criteria
Exclusion criteria: 1. Other causes of intestinal damage: IBD, occlusive disease; 2. Steroid use; 3. Esophageal varices and other esophageal disease; 4. Aortic valve disease.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| 1. C-reactive protein (CRP) in plasma; 2. Liver Fatty Acid Binding Protein (L-FABP) in plasma and urine; 3. CO2 gap (arterial pCO2 - pCO2 stomach lumen); 4. Postoperative complications. | — |
Primary
| Measure | Time frame |
|---|---|
| Intestinal Fatty Acid Binding Protein (I-FABP) in plasma and urine. | — |
Contacts
Public ContactKostan Reisinger
P. Debeyelaan 25
Outcome results
None listed